31. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma. Issue 1 (9th October 2017) Authors: Lewin, Jeremy; Garg, Swati; Lau, Beatrice Y.; Dickson, Brendan C.; Traub, Frank; Gokgoz, Nalan; Griffin, Anthony M.; Ferguson, Peter C.; Andrulis, Irene L.; Sim, Hao‐Wen; Kamel‐Reid, Suzanne; Stockley, Tracy L.; Siu, Lillian L.; Wunder, Jay S.; Razak, Albiruni R.A. Journal: International journal of cancer Issue: Volume 142:Issue 1(2018) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Impact of cisplatin dose and smoking pack-years in human papillomavirus–positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. (September 2019) Authors: Oliva, Marc; Huang, Shao Hui; Xu, Wei; Su, Jie; Hansen, Aaron R.; Bratman, Scott V.; Ringash, Jolie; Jang, Raymond; Cho, John; Bayley, Andrew; Hope, Andrew J.; Chen, Eric; Giuliani, Meredith; Waldron, John; Weinreb, Ilan; Perez-Ordonez, Bayardo; Chepeha, Douglas; Kim, John; O´Sullivan, Brian; Siu... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. (November 2016) Authors: Spreafico, Anna; Huang, Shao Hui; Xu, Wei; Granata, Roberta; Liu, Chen-Shin; Waldron, John N.; Chen, Eric; Ringash, Jolie; Bayley, Andrew; Chan, Kelvin K.W.; Hope, Andrew J.; Cho, John; Razak, Albiruni A.R.; Hansen, Aaron; Jang, Raymond; Perez-Ordonez, Bayardo; Weinreb, Ilan; Bossi, Paolo; Orland... Journal: European journal of cancer Issue: Volume 67(2016) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Impact of pharmacodynamic biomarkers in immuno-oncology phase 1 clinical trials. (September 2022) Authors: Salawu, Abdulazeez; Hernando-Calvo, Alberto; Chen, Rachel Y.; Araujo, Daniel V.; Oliva, Marc; Liu, Zhihui A.; Siu, Lillian L. Journal: European journal of cancer Issue: Volume 173(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. P-88 First-Line Pembrolizumab With or Without Lenvatinib in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 3 LEAP-010 Study. (July 2021) Authors: Harrington, Kevin; Siu, Lillian L.; Burtness, Barbara; Cohen, Ezra; Licitra, Lisa; Rischin, Danny; Zhu, Ying; Okpara, Chinyere E.; Pinheiro, Cecilia; Swaby, Ramona F.; Machiels, Jean-Pascal; Tahara, Makoto Journal: Oral oncology Issue: Volume 118(2021)Supplement Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin. Issue 22 (1st September 2020) Authors: Hassan, Raffit; Alewine, Christine; Mian, Idrees; Spreafico, Anna; Siu, Lillian L.; Gomez‐Roca, Carlos; Delord, Jean‐Pierre; Italiano, Antoine; Lassen, Ulrik; Soria, Jean‐Charles; Bahleda, Rastilav; Thomas, Anish; Steinberg, Seth M.; Peer, Cody J.; Figg, William D.; Niederfellner, Gerhard; Méress... Journal: Cancer Issue: Volume 126:Issue 22(2020) Page Start: 4936 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. (October 2019) Authors: Jones, Robin L.; Ratain, Mark J.; O'Dwyer, Peter J.; Siu, Lillian L.; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith M.P.G.M.; Evans, T.R. Jeffry; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jea... Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time‐varying clearance. Issue 5 (25th December 2022) Authors: Hwang, Michael; Chia, Yen Lin; Zheng, Yanan; Chen, Cecil Chi‐Keung; He, Jimmy; Song, Xuyang; Zhou, Diansong; Goldberg, Sarah B.; Siu, Lillian L.; Planchard, David; Peters, Solange; Mann, Helen; Krug, Lee; Even, Caroline Journal: British journal of clinical pharmacology Issue: Volume 89:Issue 5(2023) Page Start: 1601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Pretreatment neurocognitive function and self‐reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort. Issue 9 (17th April 2018) Authors: Bernstein, Lori J.; Pond, Gregory R.; Gan, Hui K.; Tirona, Kattleya; Chan, Kelvin K.; Hope, Andrew; Kim, John; Chen, Eric X.; Siu, Lillian L.; Razak, Albiruni R. Abdul Journal: Head & neck Issue: Volume 40:Issue 9(2018) Page Start: 2029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6). (February 2017) Authors: Ringash, Jolie; Waldron, John N.; Siu, Lillian L.; Martino, Rosemary; Winquist, Eric; Wright, Jim R.; Nabid, Abdenour; Hay, John H.; Hammond, Alex; Sultanem, Khalil; Hotte, Sebastien; Leong, Carson; El-Gayed, Ali Abdel Halim; Naz, Farah; Ramchandar, Kevin; Owen, Timothy E.; Montenegro, Alexander;... Journal: European journal of cancer Issue: Volume 72(2017) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗